Top Suppliers:I want be here

73604-30-5

73604-30-5 structure
73604-30-5 structure
  • Name: (-)-Bicuculline methobromide
  • Chemical Name: 6-(6,6-dimethyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-6-ium-5-yl)-6H-furo[3,4-g][1,3]benzodioxol-8-one,bromide
  • CAS Number: 73604-30-5
  • Molecular Formula: C21H20BrNO6
  • Molecular Weight: 462.29100
  • Catalog: Signaling Pathways Membrane Transporter/Ion Channel GABA Receptor
  • Create Date: 2018-02-19 08:00:00
  • Modify Date: 2024-01-04 16:12:49
  • (-)-Bicuculline methobromide (l-Bicuculline methobromide) is a potent GABAA receptor antagonist. (-)-Bicuculline methobromide blocks afterhyperpolarizations (AHPs) mediated by Ca2+-activated K+ channels in various types of neurons[1].

Name 6-(6,6-dimethyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-6-ium-5-yl)-6H-furo[3,4-g][1,3]benzodioxol-8-one,bromide
Synonyms Guvacine hydrochloride
MFCD00055149
Description (-)-Bicuculline methobromide (l-Bicuculline methobromide) is a potent GABAA receptor antagonist. (-)-Bicuculline methobromide blocks afterhyperpolarizations (AHPs) mediated by Ca2+-activated K+ channels in various types of neurons[1].
Related Catalog
Target

GABAA[1]

In Vivo (-)-Bicuculline methobromide (0.6 nmol/rat) attenuates the antiallodynic effect of Neurotropin[2]. Animal Model: Rat L5-SNL model[2] Dosage: 0.6 nmol/rat Administration: Intrathecal injection, 5 minutes before administration of Neurotropin (100 NU/kg, i.v.) Result: Attenuated the antiallodynic effect of Neurotropin.
References

[1]. Seutin V, et al. Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol Sci. 1999 Jul;20(7):268-70.

[2]. Okazaki R, et al. The antiallodynic effect of Neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation. Anesth Analg. 2008 Sep;107(3):1064-9.

Molecular Formula C21H20BrNO6
Molecular Weight 462.29100
Exact Mass 461.04700
PSA 63.22000
Safety Phrases S24/25
RIDADR UN 1544 6.1/PG 2
Packaging Group III
Hazard Class 6.1(b)